CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Effects of empagliflozin on oxidative stress and endothelial dysfunction in STZ-induced Type 1 diabetic rat
DOI 10.1055/s-0034-1375104
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Oelze, S Kröller-Schön, M Mader, E Zinßius, P Stamm, M Hausding, E Mayoux, P Wenzel, E Schulz, T Münzel, A Daiber
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe05/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background, methods: In diabetes, cardiovascular complications are associated with endothelial dysfunction and oxidative stress. Empagliflozin, as a selective sodium glucose cotransporter (SGLT) 2 inhibitor in clinical development, offers a promising novel approach for the treatment of type 2 diabetes by enhancing urinary glucose excretion. The aim of the present study was to test whether treatment with Empagliflozi…
Zitieren
Zitierempfehlung
M Oelze, S Kröller-Schön, M Mader, E Zinßius, P Stamm, M Hausding, E Mayoux, P Wenzel, E Schulz, T Münzel, A Daiber (2014) Effects of empagliflozin on oxidative stress and endothelial dysfunction in STZ-induced Type 1 diabetic rat. Diabetologie und Stoffwechsel (05). https://doi.org/10.1055/s-0034-1375104
Mit CareLit weiterarbeiten